Accordingly, in a randomized double-blind control study, a single dose of ketamine infusion caused a significant decrease in serum TNF-alpha levels 40 min after infusion in patients with treatment-resistant depression, and this was associated with a reduction in depression symptoms as assessed by depressive rating scores [95]. This evidence concerns the gene TNF and major depressive disorder.